S&P assigns preliminary 'BBB+' rating to Sun Pharma
S&P assigned Sun Pharmaceutical Industries a preliminary 'BBB+' rating with a stable outlook.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.